BLT.AX : Summary for BENITEC FPO - Yahoo Finance

U.S. Markets closed

Benitec Biopharma Limited (BLT.AX)


ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.09-0.01 (-5.00%)
At close: 10:25 PM EST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.10
Open0.10
Bid0.11 x
Ask0.10 x
Day's Range0.09 - 0.10
52 Week Range0.09 - 0.40
Volume111,360
Avg. Volume234,120
Market Cap16.7M
BetaN/A
PE Ratio (TTM)-0.90
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswirelast month

    Benitec initiates a strategic engagement with NantVentures

    NASDAQ: BNTCW) ("Benitec") announces that it has commenced a strategic engagement with NantVentures.  NantVentures was founded by Dr. Patrick Soon-Shiong and serves as the private investment arm of NantWorks and California Capital. The strategic engagement includes an immediate placement to Nant Capital, LLC, an investment entity associated with NantVentures, of 29,305,819 fully paid ordinary shares in Benitec, representing 19.99% of its existing issued capital for a post-issue holding of 16.67%.

  • PR Newswire4 months ago

    Benitec announces restructuring of Senior Executive team

    NASDAQ: BNTCW) announces the appointment of Mr Greg West as Chief Executive Officer, Dr Cliff Holloway to the combined role of Chief Business and Operating Officer and Mr Bryan Dulhunty as Chief Financial Officer.

  • PR Newswire6 months ago

    Benitec Biopharma Interim Report for the Nine Months Ended March 31, 2016

    SYDNEY, May 24, 2016 /PRNewswire/ -- Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today lodged its Interim Report for the nine months ended March 31, 2016. The report includes the ...